Desperate to protect its people and to deflect growing international criticism of how it handled the outbreak, it has slashed red tape and offered resources to drug companies. Four Chinese companies have started testing their vaccine candidates on humans, more than the United States and Britain combined.
The need is urgent. More than 247,000 people have died globally, by official figures as of Monday, and the true count is probably much higher. The coronavirus remains stubbornly difficult to stamp out. Even China, which officially appears to have tamed the spread, has suffered from sporadic outbreaks.
But in an illustration of how difficult it will be to find a safe and effective treatment, Huang grew dizzy and sick. Instead, many invest more in selling and distribution, a large chunk of which includes managing relationships with local disease control centers. Experts say that creates incentives for corruption.
The Wuhan institute was involved in a 2018 scandal in which defective vaccines for diphtheria, tetanus, whooping cough and other conditions were injected into hundreds of thousands of babies. China imposed a $1.3 billion fine on another virus-maker involved, Changchun Changsheng. The scandal led to the firing of dozens of officials and pledges of a swift industry cleanup.
Sinovac, the Wuhan institute, and its parent, China National Biotec Group, did not respond to requests for comment. “Of course, I was worried at the beginning,” she said. “To say you’re not at all worried is impossible, right?”
Magandang Gabi po homihingi po ako NG to long na ma paayos po ung racal motor ko para po magamit kopo sa trabaho kasi po nahihirapan na ako mag bike may edad na po ako 44 years old na ako pls Call me 09993129120 May 4 2020 Monday Novaliches rp ouezon city po ako